Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinostamustine in newly diagnosed MGMT-unmethylated glioblastoma
NCT03452930Phase 1Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2018
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tinostamustine in glioblastoma (GBM), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2018; status: completed.
02
Drugs
tinostamustine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT03452930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03452930.